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ANNOUNCEMENT 
The Second Annual International Summit on "Cutaneous Antifungal Therapy: Update on 
Management and New Therapy for the Clinician" will be held November 10-13,1994 at The 
Four Seasons Hotel, Boston, Massachusetts. The Co-sponsors and Scientific Program Commit-
tee are Boni E. Elewski, M.D., Case Western Reserve University and University Hospitals of 
Cleveland; Richard B. Odom, M.D., University of California, San Francisco; R.J. Hay, D.M., 
F.R.C.P., M.R.C.Path., St. John'S Institute of Dermatology, London; Hideoki Ogawa, M.D., 
Ph.D., Juntendo University, Tokyo. 
Accreditation: The American Academy of Dermatology has certified that this educational 
activity has been recognized for 24 hours of AAD Physician's Category I credit. The Interna-
tional Summit has been certified for 18.25 hours and the Mycology Workshop has been 
recognized for 5.5 hours. 
BriifProgram Description: Speakers from Europe, North American, South America, and Asia 
will convene to present state-of-the-art lectures on the latest scientific and clinical advances in 
the field of cutaneous antifungal therapy. In addition, there will be a mycology workshop, 
stimulating panel discussions, scientific poster and oral presentations, and scheduled social 
events. Major topics include tinea capitis, yeast infections, fungal foot infections, onychomyco-
sis, and systemic infections. 
For more information call Educational Meeting Management, Inc., 23550 Commerce Park 
Road, Suite 2 Beachwood, OH 44122. Phone (216) 831-6080; FAX (216) 831-0032. 
